PAF-study: results on quality of life 179 7 Figure 1. Median Short-Form Rand-36 scores total group before and after treatment. 0 10 20 30 40 50 60 70 80 90 100 Health change Mental health Emotional role Social functioning General health Vitality Physical role Bodily pain Physical functioning Baseline Post-Treatment According to the mean estimated difference between groups at 8-week follow-up, no significant differences were found in the different domains of the RAND-36 (Table 2). Repeated measurement analysis showed more improvement in all domains in time from baseline to follow-up at 20 weeks in the PFPT- group compared to postponed PFPT- group although these differences were not significant (Figure 2). Pain For the group as a whole, the VAS was significantly reduced from baseline to followup at 8 weeks (mean estimated difference 1.98; 95% CI 1.55–2.42, p< 0.001) and remained significant at 20-week follow-up (p<0.001) (Table 2). geen enter. The vas pain score moet eronder staan The VAS pain score was significantly reduced in both the PFPT and the postponed PFPT group at 8 weeks from baseline (p<0.001). At 20-week follow-up, the VAS pain score in the PFPT group and postponed PFPT group further decreased and remained significant compared to baseline (p<0.001). The difference between the groups as regards change in the mean pain intensity scores at 8 weeks from baseline was 2.48 (95% CI − 3.20 to − 1.75; p<0.001) favoring the PFPT group. At 20 weeks, no significant mean difference in VAS scores was found between groups (p=0.269).
RkJQdWJsaXNoZXIy MTk4NDMw